INTRODUCTION
============

Gamma-aminobutyric acid (GABA) is the main inhibitory transmitter in the adult mammalian brain. GABAergic interneurons regulate neuronal excitability, synaptic integration, and the dynamic of network oscillations and as such are important for many cognitive functions. Recent advances, however, indicate that GABA can act beyond its classical role in synaptic communication and may function as an important developmental signal, being able to modulate nearly all key steps of neuronal network formation including cell survival and migration, neuritic growth and guidance, synapse formation and maturation ([@B83]; [@B8]; [@B95]).

Most of the trophic actions of GABA have been attributed to the activation of the ionotropic, chloride permeable, GABA~A~ receptors. Indeed, early in development, GABA~A~ receptors activation induces a membrane depolarization and an increase in intracellular calcium concentration ([@B83]; [@B8]). The depolarizing to hyperpolarizing shift of GABA~A~ receptor-mediated response results from a developmental decrease in intracellular chloride concentration brought about by the increased contribution of the potassium/chloride co-transporter, KCC2, which extrudes chloride from the cells ([@B89]). The role of GABA~A~ receptors in neuronal development has been highlighted in studies in which the depolarizing/hyperpolarizing conversion of GABA responses is modified *in vitro* ([@B21]) and *in vivo* ([@B39]; [@B17]; [@B88]; [@B106]). However, GABA also activates metabotropic GABA~B~ receptors (GABA~B~-Rs) and accumulating evidence indicate that these receptors may promote cell migration, differentiation, and synaptogenesis. The goal of this review is to recapitulate the current knowledge about the overlooked role of GABA~B~-Rs in neuronal development.

A SHORT INTRODUCTION TO THE BASIC PROPERTIES OF GABA~**B**~-R SIGNALING
=======================================================================

GABA~B~ receptors are metabotropic receptors coupled to G~αi/o~-guanosine triphosphate (GTP) type protein which inhibits adenylate cyclase and gates ion channels ([@B14]; [@B15]). Released GABA can feed back onto GABA~B~ auto-receptors located on GABAergic terminals, and/or spillover to activate hetero-synaptic GABA~B~-Rs on neighboring glutamatergic terminals. Activation of the pre-synaptic GABA~B~-Rs inhibits neurotransmitter release through multiple targets including inactivation of voltage-dependent calcium channels ([@B78]), gating of potassium conductance to shunt pre-synaptic action potentials ([@B97]), reduction of vesicle priming ([@B92]), or interaction with the exocytosis machinery ([@B12]). Released GABA also signals onto post-synaptic GABA~B~-Rs located on dendritic shaft and spines ([@B62]). Activation of these receptors generates slow (100-150 ms) inhibitory potentials via the opening of G-protein activated-inward rectifying potassium channels (G-protein-regulated inwardly rectifying K^+^ channels, GIRKs also known as inwardly rectifying potassium, Kir3 channels; [@B33]).

The cloning of GABA~B~-Rs in the late 1990s has led to the identification of two GABA~B~ gene products: the GABA~B1~ and GABA~B2~ subunits ([@B51]). Recombinant experiments showed that heterodimerization of GABA~B1~ and GABA~B2~ subunits is mandatory for cell surface expression and coupling to G-protein ([@B48]; [@B52]; [@B109]). Coiled--coil interactions in the C-terminal domain of the newly synthesized subunits in the endoplasmic reticulum masks a retention signal present on the C-terminal domain of the GABA~B1~ subunit so that only GABA~B1~ subunit assembled with GABA~B2~ subunit are trafficked to the cell surface. GABA~B1~/GABA~B2~ subunits assembly is also mandatory for agonist-induced signaling. In the heterodimeric GABA~B~-Rs, GABA~B1~ subunit is responsible for binding of GABA, whereas the GABA~B2~ subunit is necessary for G-protein coupling ([@B90]). Transgenic mice lacking the GABA~B1~ subunit confirm that heterodimeric assembly is required to provide fully functional receptors *in vivo* since GABA~B1~^-/-^ mice do not exhibit detectable electrophysiological, biochemical, or behavioral responses to GABA~B~-R agonists ([@B86]; [@B94]; [@B87]). Deletion of the GABA~B2~ subunit also abolished all known response to GABA~B~-R agonists ([@B38]). The GABA~B2~^-/-^ mice, however, exhibit an atypical baclofen response, namely an inhibition of potassium channels, which is not observed in wild type (WT) mice ([@B38]). Thus GABA~B1~ subunits could assemble into functional receptor but such homomeric assembly may be a consequence of the knockout of the GABA~B2~ subunit ([@B38]).

The GABA~B1~ subunit further exists under two isoforms, named GABA~B1a~ and GABA~B1b~, which differ by a pair of sushi domains on the N-terminal of the GABA~B1a~ subunit ([@B51]; [@B10]). The two isoforms have similar pharmacological and physiological properties in heterologous expression systems precluding determination of the functional significance of this molecular diversity. The demonstration that the GABA~B1a~ and GABA~B1b~ isoforms contribute to distinct native GABA~B~-Rs and convey different functions was made possible by the generation of mice deficient in GABA~B1a~ or GABA~B1b~ isoform. Using this knocking down approach, it was shown that the GABA~B1a~ isoform is preferentially targeted to the pre-synaptic glutamatergic terminals and assemble with GABA~B2~ subunit to form hetero-receptors whereas both GABA~B1a~ and GABA~B1b~ isoforms assemble with the GABA~B2~ subunit into auto-receptors at pre-synaptic GABAergic terminals ([@B105]; [@B41]). On the post-synaptic side, although both isoforms are present, GABA~B1b~ isoform provides the majority of coupling with GIRK ([@B105]) and inhibition of dendritic calcium spikes ([@B84]).

ONTOGENY OF GABA~B~ RECEPTOR-MEDIATED RESPONSES
===============================================

Information regarding the distribution pattern and subcellular distribution of the GABA~B~ receptor subunits is crucial to gain insight into the contribution of these receptors to brain development. Several evidences indicate that both GABA~B1~ and GABA~B2~ subunits are expressed in the developing brain although some temporal and spatial differences exist, suggesting that the regulatory mechanisms for these subunits may differ. At the embryonic day (E) 11, GABA~B1~ transcripts are detected in the rat brain whereas the GABA~B2~ transcripts are below the level for detection ([@B55]; [@B66]; [@B73]). At E14, both transcripts are detected in most brain regions except in the olfactory bulb and striatum where GABA~B2~ transcripts remain barely detectable until E17 ([@B73]). At the protein levels, in a pioneer study, [@B102] performed quantitative receptor autoradiography with (^3^H)GABA to study the ontogeny of GABA~B~ binding sites in the rat brain. They reported that GABA~B~ binding levels is detected at early postnatal stages and peak at regionally specific times during the three first postnatal week of life. Western blot and immuno-histochemical analysis confirm that GABA~B1~ and GABA~B2~ subunits are present in the developing brain ([@B6]; [@B65], [@B66]; [@B73]; [@B9]; [@B68]). These studies further show distinct expression patterns between GABA~B1a~ and GABA~B1b~ subunits ([@B30]; [@B31]). The GABA~B1a~ subunit is highest during the first postnatal week of life, whereas GABA~B1b~ subunit progressively increases to reach its maximum by P10 ([@B30]). Both subunits reach adult levels by the end of the third postnatal week of life. The expression of the GABA~B1~ and GABA~B2~ subunits overlaps in many regions but some laminar and cellular distinctions are found. For instance at birth, the GABA~B1~ labeling is uniform across all neocortical layers, while the GABA~B2~ labeling is most intense in the layers I and V--VI ([@B31]). Similarly, in the hippocampus, GABA~B1~ expression predominates in the pyramidal layer while GABA~B2~ is mostly expressed in the dendritic layers ([@B31]). In the gerbil medial superior olive (MSO), the GABA~B1~ expression changes from a predominantly dendritic to a somatic location during development ([@B43]). Double immuno-labeling indicate that the GABA~B1~ and GABA~B2~ subunits co-localize in neurons of the marginal zone and subplate, while tangentially migrating neurons in the intermediate zone (iz) and Cajal--Retzus cells in the layer I only express the GABA~B1~ subunit ([@B65]). At the electron microscopic level, the GABA~B1~ and GABA~B2~ subunits are found at both pre- and post-synaptic levels in the developing cerebellum ([@B68]), neocortex ([@B65]), and hippocampus ([@B66]) at early postnatal development stages. At the post-synaptic levels, both subunits are present on dendritic shaft and spines at extra-synaptic and peri-synaptic sites. Of note is the transient expression of GABA~B1~ and GABA~B2~ subunits on glial cells in the hippocampus ([@B66]) and cerebellum ([@B68]). Activation of these receptors induce calcium transient in astrocytes in newborn rat hippocampal slices ([@B76]) that may in turn impact the development of neuronal networks.

Studies investigating the ontogeny of GABA~B~-R mediated responses further indicate that GABA~B~-Rs are present and functional early in development albeit some regional distinctions in the signaling pathway activated. Post-synaptic GABA~B~-mediated opening of GIRK to baclofen applications are not recorded at birth in the hippocampus ([@B34]; [@B16]; [@B80]; [@B103]) and neocortex ([@B67]; [@B32]; [@B56]), while pre-synaptic GABA~B~-R mediated inhibition is already functional and controls both GABA and glutamate release ([@B67]; [@B32]; [@B75]; [@B16]). Post-synaptic GABA~B~-mediated responses increase until the middle of the second postnatal week and remain stable thereafter ([@B67]; [@B32]; [@B34]; [@B56]). Hippocampal neuronal cultures from E18 rat embryos also lack of post-synaptic GABA~B~-R mediated currents until 11 days *in vitro* ([@B27]) although they express both GABA~B1~ and GABA~B2~ subunits ([@B73]). When transfected to overexpress GIRK, a typical GABA~B~-R mediated potassium outward current could be induced in these neurons ([@B27]), suggesting that the availability of the GIRK channels is the likely limiting factor for the appearance of functional post-synaptic GABA~B~-R mediated inhibition (but see [@B23]).

Other evidence confirm that the post-synaptic GABA~B~-Rs are present and interact with G-proteins at early developmental stages. For instance, GABA~B~-R agonists decrease forskolin-induced cyclic-adenosine monophosphate (cAMP) levels in E18 neocortical neuronal cultures ([@B73]; [@B13]) and increase intracellular calcium concentration in some dissociated embryonic cortical neurons ([@B1]). In the developing rat hippocampus, baclofen induces a rapid increase of protein kinase C (PKC) activity ([@B101]). Patch-clamp recordings performed on developing chick retina have shown that GABA~B~-Rs failed to activate potassium currents, while they inhibit calcium channels ([@B18]). Similarly, in the developing rat hypothalamus baclofen depresses the post-synaptic calcium rise induced by glutamate- and GABA~A~-R agonists ([@B81], [@B82]). A completely different situation has been observed in the gerbil MSO where GIRK currents activated by post-synaptic GABA~B~-Rs disappear during development ([@B43]). How this developmental change in GABA~B~-R mediated responses is regulated in presently unknown.

Altogether, these observations show that post-synaptic GABA~B~-Rs are present and functional early in development, although they are not yet involved in the control of cell excitability via the opening of post-synaptic GIRK in most developing brain regions. At that stage, they are, however, coupled to signaling pathways that may instruct or modulate neuronal development.

THE CONDITIONS FOR THE ACTIVATION OF GABA~B~-RS ARE GATHERED IN THE DEVELOPING BRAIN
====================================================================================

To contribute to neuronal development, GABA~B~-Rs must be activated by ambient GABA. Early in development, GABA is released from growth cones ([@B96]; [@B36]) or in paracrine non-vesicular manner ([@B25]) providing an endogenous and local source of GABA. Using a microchemotaxis assay, [@B6] have shown that E18 cortical plate (cp) neurons release GABA and taurine, creating a gradient that direct cell migration via the GABA~A~-Rs and GABA~B~-Rs. When GABAergic synapses are established, released GABA must diffuse to activate extra-synaptic and/or peri-synaptic GABA~B~-Rs. Consequently, GABA~B~-R mediated responses are induced when a population of interneurons are synchronously activated or facilitated when the GABA transporters are blocked ([@B26]; [@B98]; [@B46]; [@B93]), both procedures promoting GABA spillover. One characteristic feature of developing neuronal networks is the presence of a primitive network-driven synaptic activity both *in vivo* and *in vitro* (reviewed in [@B54]; [@B8]). During this patterned activity, GABAergic interneurons fired synchronously ([@B53]; [@B54]), a condition that allows diffusion of GABA into the extracellular space. This diffusion is facilitated by the presence of a large extracellular space and a relative immaturity of the reuptake mechanisms ([@B16]; [@B25]). Combined with synchronous release of GABA, these immature features create the adequate conditions for GABA spillover and activation of GABA~B~-Rs in the developing brain.

Applications of specific antagonists have been used to reveal the activation of GABA~B~-Rs by ambient GABA. Application of GABA~B~-R antagonists reduces the incidence of calcium spikes in the embryonic *Xenopus* spinal cord ([@B91]) and increases the basal level of cAMP in embryonic rodent cortex ([@B13]). In the developing rat hippocampus, the GABA~B~-R antagonists prolong the duration of the network-driven synaptic activity, termed giant depolarizing potentials (GDPs; [@B7]; [@B75]). A similar lengthening of GDPs was observed in newborn GABA~B1~^-/-^ mice ([@B29]) or after desensitization of GABA~B~-Rs following prolonged activation with baclofen ([@B99], [@B100]). Interestingly, when the GDPs are blocked, the GABA~B~-R antagonist has no effect on GABAergic and glutamatergic synaptic activity ([@B22]; [@B29]), supporting the idea that synchronous activation of GABAergic neurons ([@B53]), and subsequent GABA spillover, is required for GABA~B~-R activation. A similar GABA~B~-R dependent control of network-driven synaptic activity has been observed in developing retina ([@B18]), hypothalamus ([@B81], [@B82]), and cortex ([@B82]; [@B56]). In all these structures, the application of GABA~B~-R antagonists increase the frequency and/or duration of synaptic-driven intracellular calcium oscillations, showing that synaptically released GABA exerts a tonic inhibitory control of ongoing synaptic activity acting through GABA~B~Rs.

Altogether, these observations show that ambient GABA activates GABA~B~-Rs early in development, a prerequisite for a possible contribution of GABA~B~-Rs to neuronal development.

NEUROTROPHIC ACTIONS OF GABA~B~-RS
==================================

WHEN GABA~B~-RS MODULATE NEURONAL MIGRATION
-------------------------------------------

After their last division, immature postmitotic neurons migrate away from the germinal layers to reach their final position where they differentiate and establish appropriate synaptic connections. Among the many factors involved ([@B70]), GABA~B~-Rs have been reported to modulate migration or motility of embryonic spinal cord neurons ([@B2], [@B5]), embryonic hypothalamic neurons ([@B24]; [@B74]), and oligodendrocytes ([@B69]). However, the best documented contributions of GABA~B~-Rs to neuronal migration have been obtained from the studies performed in the cortex. Two modes of migration coexist in the cortex: a radial migration of glutamatergic pyramidal cells from the ventricular/subventricular zone (VZ/SVZ) to the cp and a tangential migration of GABAergic neurons from the ganglionic eminences to the cp. The cortical VZ, cp, and tangentially migrating neurons express GABA~B~ receptors ([@B6]; [@B64]; [@B13]) and both radial and tangential migration are modulated by GABA~B~-Rs (**Figure [1](#F1){ref-type="fig"}**). The first evidence that GABA~B~-Rs modulate cortical cell migration have been obtained on dissociated embryonic cortical neurons. Starting from E15, GABA induces both chemotaxis (directed migration along a chemical gradient) and chemokinesis (random motility; [@B1], [@B4]). These effects are mimicked by GABA~B~-R agonists, prevented by GABA~B~-R antagonists and suppressed by pertussis toxin, an inhibitor of G~o/i~ proteins ([@B4]). Interestingly, both migratory behaviors are eliminated when the cells are loaded with the calcium chelator BAPTA-AM \[1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis(acetoxymethyl ester)\], indicating that cytosolic levels of calcium are important for GABA-induced cell motility. Accordingly, baclofen elevates intracellular calcium concentration in a subset of cells derived from E17 cortices ([@B1]). Using microdissection technique, [@B4] have further shown that GABA~B~-Rs stimulates motility of glutamic acid decarboxylase (GAD)-positive cp neurons and directs a subset of GAD-negative VZ neurons to migrate, suggesting that these receptors may have a role in modulating radial and tangential modes of migration. Organotypic slices cultures and treatment with different GABA receptor antagonists were used to show that endogenous released GABA directs cortical cells to migrate. Thus, organotypic slice cultures treated with the GABA~B~-R antagonist CGP52342 display an accumulation in the VZ/SVZ of tangentially migrating neurons originating from the ganglionic eminences (**Figure [1A](#F1){ref-type="fig"}**; [@B64]). Similarly, treatment with the GABA~B~-R antagonist saclofen prevents most VZ BrdU-positive postmitotic neurons from entering into the cp ([@B3]). Pharmacological approaches show that GABA acts on both metabotropic and ionotropic GABA-Rs to direct neurons to their final position in the cp: GABA~C~-Rs signal cells to leave the VZ/SVZ and enter the iz; the GABA~B~-Rs direct cells to leave the iz to enter in the cp; and the GABA~A~-Rs provide a stop signal as the cells approach their target destination in the cp ([@B3]).

![**GABA**~**B**~-Rs modulate radial and tangential migration. **(A)** E15 brain slices were cut at 300 μm and 4-chloromethyl benzoyl amino tetramethyl rhodamine (CMTMR)-coated particles were placed in the medial ganglionic eminence (MGE) of each hemisphere to label the tangentially migratory neurons. The slices were then incubated for 24 h *in vitro* in normal culture medium (a,c) or in the presence of 1 μM of the GABA~BR~ antagonist, CGP52432 (b,d). After the incubation period, the slices were fixed and counterstained with 0.002% bis-benzimide (blue) to reveal the different cortical compartments and brain structures. In control conditions more CMTMR-labeled cells located at the lower intermediate zone (LIZ) were observed (c) while in the presence of CGP52432 the majority of CMTMR-labeled cells were observed in the ventricular/subventricular zones (VZ/SVZ; d). Asterisks at (c,d) represent where the majority of the CMTMR-positive cells were localized. Abbreviations: ctx, cortex; LIZ, lower intermediate zone; mz, marginal zone; VZ, ventricular zone. Scale bars: a,b 200 μm, c,d 100 μm. Modified with permission from [@B64]. **(B)** Confocal images of tdTomato fluorescence in coronal sections of rat somatosensory cortices P16 after *in utero* transfection (at E17) with pRNAT-U6.3 (EGFP) siRNA empty vector together with pCAG-IRES-tdTomato (Tomato, Control), or functional GABA~B2~-siRNA (siRNA) together with Tomato construct. Dotted white lines delimitate the boundaries of the cortical layers. Note the presence of ectopic neurons that did not complete radial migration in the layers V and VI. Scale bar: 150 μm. LII--LIV, layer II--IV; WM, white matter. Modified with permission from [@B13].](fncel-07-00206-g001){#F1}

A recent study has addressed the role of GABA~B~-Rs on neuronal migration *in vivo* ([@B13])*.* To this aim, short interfering RNAs (siRNAs) targeting the GABA~B2~ subunit have been electroporated at E15 to silence GABA~B~-Rs mediated responses in cortical pyramidal neuron progenitors ([@B13]). Most of the GABA~B2~-silenced cells do not reach their target normal target position in the cortical layer II/III but remained in the deep layers at postnatal stages, indicating that ambient activation of GABA~B~-Rs modulate the radial migration *in vivo* (**Figure [1B](#F1){ref-type="fig"}**). The authors have gathered evidence identifying the cAMP/liver kinase B1 (LKB1) signaling as downstream effector of GABA~B~-Rs ([@B13]). Indeed, the silencing of the GABA~B2~ subunit increases the immuno-staining against the phosphorylated form of LKB1 at the protein kinase A (PKA) site (pLKB1). Moreover while the overexpression of both LKB1 and constitutively active pLKB1 results in similar migration defects, the overexpression GABA~B~-Rs only rescues the LKB1-induced defects, indicating that these receptors modulate LKB1 activity through the cAMP/PKA pathway. Finally, the silencing of LKB1 expression rescues the migration defects induced by GABA~B2~ down expression *in vivo*. Altogether these data indicate that GABA~B~-Rs affect neuronal migration by modulation of cAMP/LKB1 pathway *in vivo*.

If endogenous GABA directs the migration of cortical neurons, an endogenous source of GABA must exist. Because GABA exerts chemo-attractant effect and directs migration of cortical VZ neurons into the cp, a likely candidate for the endogenous source of GABA is the cp cells. To test this hypothesis, dissociated VZ cortical cells were placed in the upper half of a chemotaxis chamber opposite to cp neurons placed in the lower half ([@B6]). In this condition, the cp cells induce the VZ cells to migrate, an effect prevented by the GABA~B~-R antagonist saclofen. This observation suggests that cp cells release a diffusible signal that stimulates migration. In agreement with this hypothesis, high performance liquid chromatography (HPLC) analysis reveals that cp neurons release GABA and taurine, and that both molecules stimulate VZ migration in a GABA~B~-R dependent manner ([@B6]). More recent studies have identified the tangentially migrating interneurons as the possible source of released GABA ([@B71]; [@B13]).

WHEN GABA~B~-RS MODULATE CELL DIFFERENTIATION
---------------------------------------------

Proper neuronal specification and acquisition of correct neurotransmitter phenotype is crucial for the functioning of the nervous system. Knockdown of GAD, the GABA synthetizing enzyme, has been used in *Xenopus* embryos to investigate the contribution of GABA in this process ([@B91]). The silencing of GAD results in a decreased incidence of GABA and glycine immuno-reactive cells and increased incidence of glutamate and acetylcholine (Ach) immuno-reactive cells in the *Xenopus* spinal cord. Agarose beads loaded with a GABA~B~-R antagonist and implanted in the neural tube pheno-copied the effects of GAD knocking down. With the observation that both the GABA~B1~ and GABA~B2~ subunits are detectable in the brain and spinal cord at the corresponding developing stage ([@B49]), these data show that ambient GABA may control neurotransmitter specification in the *Xenopus* embryos *in vivo*. The mechanisms involved are not entirely known but required the activation of PKA and PKC which in turn stimulate generation of calcium spikes in embryonic spinal neurons ([@B91]).

WHEN GABA~B~-RS MODULATE NEURITIC OUTGROWTH AND GROWTH CONE GUIDANCE
--------------------------------------------------------------------

To ensure accurate targeting, neurons use different regulated mechanisms that provide growth and directional cues to advancing growth cones. Among the many factors, a large amount of evidence indicates that GABA can modulate neurite outgrowth *in vitro* in different brain regions and species (for review, see [@B95]). Although most studies have focused on the contribution of GABA~A~-Rs, there are some indications that GABA~B~-R activation also modulates neuritic growth and growth cone motility both *in vitro* and *in vivo*.

The first evidence that GABA~B~-Rs may affect neurite outgrowth was provided by [@B77]. They have shown that the administration of the GABA~B~-R agonist baclofen to cultures obtained from chick tectum or rat cerebellum inhibits neurite outgrowth, while administration of the GABA~B~-R antagonist saclofen leads to opposite effect ([@B77]). Similar to the earlier study by [@B77], baclofen has been reported to inhibit the neurite outgrowth and growth cone motility of mice spinal cord ([@B11]) and olfactory bulb ([@B85]) neurons kept in cultures. GABA~B~-Rs also modulate the neurite outgrowth of cultured cortical neurons ([@B13]). Indeed, cortical neurons treated with baclofen exhibit longer and more branched dendrites associated with shorter and less branched axons. Conversely, treatment with the GABA~B~-R antagonist CGP55845 results in shorter dendrites and longer axons. Interestingly, siRNA transfection to silent the expression of the GABA~B2~ subunit also shortens dendritic length and promotes axonal length ([@B13]). With this approach, the post-synaptic GABA~B~-R mediated responses were silenced in a small population of neurons that grow in a normally developing network, hence ruling out impact on the overall network activity, in contrast to the pharmacological approach in which the pre- and post-synaptic responses were abolished in every cell. Thus, the neurotrophic action of GABA~B~-Rs is not an indirect consequence of altered synaptic activity, but rather results from the activation of post-synaptic downstream signaling pathways. GABA~B~-Rs not only modulate neuritic growth of some neuronal populations, they also modulate axon/dendrite polarity of cortical neuron *in vitro*. Baclofen inhibits axon initiation whereas CGP55845 or GABA~B2~ silencing promote axon initiation *in vitro* ([@B13]). The effects of baclofen and CGP55845 are abolished by, respectively, an activator or an inhibitor of the adenylate cyclase, indicating that GABA~B~-Rs modulate neuronal polarity through an inhibition of cAMP signaling. [@B37] have examined the effects of GABA signaling on dendritic development *in vitro* using purified neurons from the SVZ of newborn rats, intended to the olfactory bulb neurons. They found that although cells treated with the GABA~A~-R antagonist bicuculline exhibit reduced dendritic complexity, treatment with a GABA~B~-R antagonist has no significant effects. Similarly, blockade of GABA~B~-R does not affect the neuritic outgrowth of cultured cp neurons ([@B72]). These findings may suggest that either the modulation of neurite outgrowth exerted by the GABA~B~-Rs is cell type specific or that in these cultures the amount of GABA released do not reach the critical concentration allowing the activation of extra/peri-synaptic GABA~B~-Rs.

Despite a large body of data indicating a role for GABA~B~-Rs in neurite outgrowth *in vitro*, *in vivo* evidence have been provided only recently. In the *Xenopus laevis*, the axons of retinal ganglion cells (RGCs) extend through the brain toward their major target, the optic tectum. The axon growth cones of RGCs express GABA~B~-Rs, and application of baclofen stimulate RGC neurite outgrowth in cultures ([@B28]). To determine the contribution of the GABA~B~-Rs *in vivo*, [@B28] have applied the GABA~B~-R antagonist CGP54626 and found that it causes a shortening of the optic projections, indicating that ambient activation of GABA~B~-Rs controls the growth of RGC axons *in vivo*. To investigate whether GABA~B~-Rs may also modulate the neurite outgrowth of cortical pyramidal neurons *in vivo*, siRNA were electroporated *in utero* to downregulate the expression of the GABA~B2~ subunit to silence post-synaptic GABA~B~-R mediated responses ([@B13]). Morphological analysis revealed that the specific downregulation of endogenous GABA~B2~ subunit *in vivo* leads to reduced apical dendritic length and branch number, and increased axonal growth of cortical neurons. In contrast, the dendritic length and complexity of hippocampal CA3 pyramidal neurons is not altered in GABA~B1~^-/-^ knockout mice ([@B29]). This observation may suggest that GABA~B~ receptors regulate neurite outgrowth in some, but not all, brain regions or, that compensatory mechanism take place in the knockout mice (see below).

If GABA~B~-Rs can modulate neurite outgrowth, an obvious question was to determine whether they could also serve as guidance signal for axon pathfinding. To answer that question, [@B111] applied a gradient of baclofen to *Xenopus* spinal cord neurons in cultures. They found that the growth cones turn away from the baclofen gradient. Interestingly, repulsion is converted to attraction in the presence of PKC inhibitors. Pharmacological investigations show that baclofen exerts a bi-directional control of growth cone guidance through the activation of different signaling pathways: the activation of the PLC--PKC pathway leading to growth cone repulsion and the PLC-IP3 pathway that attracts the growth cone toward the baclofen source ([@B111]). Whether and which of these signaling pathways contribute to axon guidance *in vivo* remains to be elucidated.

WHEN GABA~B~-RS MODULATE SYNAPTOGENESIS
---------------------------------------

The above gathered studies indicate that activation of GABA~B~-Rs could serve as a growth and guidance signal, thereby participating in neuronal network construction. Recent evidence indicates that GABA~B~-Rs may also regulate synaptogenesis. [@B20] demonstrated in organotypic cortical slices that endogenous GABA regulates the axonal branching of basket-cell interneurons through the activation of GABA~A~ and GABA~B~ receptors. The authors found that knocking down GAD67, the major GABA synthetizing enzyme, in single basket cells results in a cell autonomous decrease in the number of peri-somatic GABAergic synapses formed by these interneurons on pyramidal cells. The beauty of this approach is that a single cell manipulation minimally impacts the overall level of synaptic activity in contrast to pharmacological manipulations. The deficit induced by the down expression of GAD67 is partially rescued by adding inhibitors of GABA uptake or GABA~A~ as well as GABA~B~ receptor agonists. These findings therefore indicate that ambient GABA, acting on both GABA~A~ and GABA~B~ receptors, contributes to the development of peri-somatic cortical inhibition. In line with GAD silencing, knockout of the GABA~B1~ subunit also results in altered development of GABAergic synaptic transmission in the mice hippocampus ([@B29]). Whole cell recordings performed on acute hippocampal slices obtained from newborn GABA~B1~^-/-^ mice reveals a lower level of miniature GABAergic synaptic activity in the mutant CA3 pyramidal neurons compared to the WT. This deficit is reproduced *in vitro* in newborn WT intact hippocampi incubated overnight with the GABA~B~-R antagonist CGP55845 or with tetrodotoxin (TTX) to block action potential-dependent synaptic activity. Importantly, the deficit induced by TTX treatment is rescued by baclofen, indicating that synaptic activation of GABA~B~-Rs by ambient GABA contributes to the functional development of hippocampal GABAergic synapses. The mechanism by which GABA~B~-Rs promote the development of GABAergic synapses likely involved regulated secretion of the brain-derived neurotrophic factor (BDNF) and subsequent activation of the tropomyosin receptor kinase (TrkB) pathway (**Figure [2](#F2){ref-type="fig"}**). Indeed, the deficit in GABAergic activity observed in WT intact hippocampi treated overnight with CGP55845 is rescued by BDNF treatment and occluded by the absence of BDNF (i.e., in intact hippocampi obtained from BDNF^-/-^ mice or treated with the BDNF/NT4 scavenger TrkB--immunoglobulin G, IgG; [@B29]). Furthermore, time lapse fluorescence imaging of BDNF--GFP expressing neurons and immuno-histochemical studies show that the activation of GABA~B~-Rs triggers a calcium-dependent secretion of BDNF *in vitro* through the activation of the phospholipase C (PLC)--PKC pathway and opening of L-type voltage-dependent calcium channels ([@B29]; [@B61]). A previous study has shown that the phosphorylation of the α-CamKII, a critical step in BDNF secretion ([@B57]), is enhanced by GABA~B~-R activation in the developing rat hippocampus ([@B112]). Therefore, post-synaptic elevation of calcium and phosphorylation of α-CamKII may underlie the GABA~B~-R induced secretion of BDNF and functional maturation of GABAergic synaptic transmission in the developing hippocampus.

![**GABA**~**B**~-Rs modulate GABAergic synaptogenesis and plasticity. The activation of GABA~B~-Rs induces the formation of diacylglycerol (DAG), activation of protein kinase C (PKC), and the opening of L-type voltage-dependent Ca^2+^ channels (L-VDCC). The intracellular Ca^2+^ rise triggers the secretion of BDNF which acting on TrkB-Rs modulate the formation and efficacy of developing GABAergic synapses.](fncel-07-00206-g002){#F2}

Brain-derived neurotrophic factor and tropomyosin receptor kinase signaling is necessary for the full development of inhibitory circuitry ([@B40]). Moreover, endogenous activation of GABA~B~-Rs ([@B75]; [@B81], [@B82]; [@B18]; [@B56]) and GABA~B~-R dependent modulation of intracellular calcium levels have been reported in several developing brain structures ([@B1]; [@B44]; [@B79]; [@B91]; [@B61]). Therefore, the GABA~B~-R induced secretion of BDNF may be important for the maturation of synaptic connections throughout the nervous system. Accordingly, a GABA~B~-R and BDNF--TrkB dependent plasticity of developing inhibitory transmission has been observed in the auditory system ([@B59], [@B60]; [@B19]) and visual cortex ([@B58]; [@B45]). In these structures, the plasticity is induced during a restricted period of development suggesting that it may have a developmental function in the refinement of initially coarse patterns of synaptic connections ([@B50]). How GABA~B~-R and BDNF are linked is presently not fully understood. However, based on the observation that bath application of BDNF rescues the inhibitory plasticity in neurons loaded with the calcium chelator BAPTA, it was proposed that the induction of the inhibitory plasticity relies on the endogenous activation of GABA~B~-Rs leading to a calcium-dependent secretion of BDNF from the target neurons, which through the TrkB pathway triggered synaptic plasticity ([@B45]; **Figure [2](#F2){ref-type="fig"}**).

THE INCONSISTENCY OF GABA~B~-R KNOCKOUT MICE
============================================

Although *in vitro* pharmacological studies indicate that GABA~B~-Rs can function as a development signal, studies of knockout mice lacking functional GABA~B~-Rs could lead to opposite conclusions. Indeed, the complete silencing of GABA~B~-Rs in mice causes behavioral alterations such as epilepsy, impaired memory, hyperalgesia, hyperthermia, and hyperactivity, highlighting the importance of GABA~B~-Rs in the appropriate functioning of the nervous system ([@B86]; [@B87]; [@B42]; [@B110]). Yet, knockout of either GABA~B1~ or GABA~B2~ subunit does not reveal significant alteration in cortical layer organization, although a role of GABA~B~-Rs in cortical migration has been identified *in vitro*. Similarly, morphological analysis of hippocampal pyramidal neurons reveals no significant alteration of GABA~B1~^-/-^ mice ([@B29]), although endogenous GABA~B~-Rs have been reported to modulate neurite growth *in vitro* ([@B77]; [@B85]; [@B13]). The same discrepancy is observed in mice knockout for the GABA-synthetizing enzyme GAD. Indeed, although GABA is scarcely detected in double knockout GAD 65 and 67, no disorders of histogenesis are observed ([@B47]). It should be mentioned, however, that a developmental phenotype has been observed in GABA~B1~^-/-^ mice, in which whole cell recordings of hippocampal slices reveal a delayed functional maturation of GABAergic synapses in the mutant mice ([@B29]). Therefore, a more detailed determination of the morphological--functional properties of the neuronal networks in GABA~B~^-/-^ mice is essential to ensure that the mutation has developmental consequences. The discrepancy between *in vitro* pharmacological studies and genetically modified mice *in vivo* may be explained by compensatory mechanisms frequently experienced by knockout mice. For instance, in the knockout GAD mice, taurine can bind GABA~B~-Rs and could potentially compensate for the absence of GABA ([@B6]). Moreover, some of the downstream signaling pathways activated by the GABA~B~-Rs are also the targets of other receptors, and activation of these receptors may substitute for the absence of functional GABA~B~-Rs. A recent study shows that silencing GABA~B~-Rs in a small population of excitatory neurons leads to ectopic positions and morphological alterations of these neurons ([@B13]), hence highlighting the contribution of GABA~B~-Rs to neuronal development *in vivo*.

CONCLUSION
==========

A large body of studies has documented the prominent role of GABA~A~-Rs to neuronal development. For several years, the possible contribution of GABA~B~-Rs has lagged behind. The studies gathered in this review indicate that GABA~B~-Rs do play a role in crucial steps of neuronal network formation, including migration, neurite growth, synapse formation and plasticity, both *in vitro* and *in vivo* (**Table [1](#T1){ref-type="table"}**). The neurotrophic action of GABA~B~-Rs raises several immediate questions. Do they play an instructive or a permissive role? What are the downstream signaling pathways involved? Does the use pharmacological drugs during pregnancy lead to GABA~B~-dependent alterations in brain construction?

###### 

Neurotrophic action of GABA~**B**~-Rs

  Structure                         Preparation                     Approach to silence GABA~B~-Rs   Consequences of GABA~B~-Rs silencing                           Reference
  --------------------------------- ------------------------------- -------------------------------- -------------------------------------------------------------- --------------
  Rat neocortex                     Dissociated neuronal cultures   GABA~B~-R antagonist             Decrease radial migration                                      [@B1], [@B4]
  Rat neocortex                     Organotypic slice cultures      GABA~B~-R antagonist             Decrease tangential migration                                  [@B64]
  Mice neocortex                    *In* *vivo*                     In utero GABA~B2~ silencing      Decrease radial migration and neurite outgrowth                [@B13]
  *Xenopus* spinal cord             *In* *vivo*                     GABA~B~-R antagonist             Inhibit phenotypic differentiation of GABA and glycine cells   [@B91]
  Chick tectum                      Dissociated neuronal            GABA~B~-R antagonist             Inhibit neurite outgrowth                                      [@B77]
  Rat cerebellum                    cultures                                                                                                                        [@B85]
  Mice olfactory bulb                                                                                                                                               [@B11]
  Mice spinal cord                                                                                                                                                  [@B13]
  Rat neocortex                                                                                                                                                     
  *Xenopus* spinal cord             Dissociated neuronal cultures   GABA~B~-R antagonist             Modulate growth cone guidance                                  [@B111]
  *Xenopus* retinal ganglion cell   *In* *vivo*                     GABA~B~-R antagonist             Inhibit axon outgrowth                                         [@B28]
  Mice hippocampus                  Acute slices                    GABA~B1~^-/-^ knockout mice      Decrease GABAergic synaptic maturation                         [@B29]
  Rat visual cortex                 Organotypic slice cultures      Single cell GAD knockout         Decrease GABAergic synaptogenesis                              [@B20]

The use of antagonists has been extremely fruitful to unmask the endogenous activation of GABA~B~-Rs and reveal their neurotrophic actions. However, because GABA~B~-Rs control the level of synaptic activity, it is often difficult with this approach to distinguish between indirect actions on synaptic activity from direct consequences of GABA~B~-R activation. However, the functional silencing of GABA~B~-Rs in a small population of neurons that minimally impact the level of synaptic activity offers an interesting alternative, and confirms that endogenous GABA~B~-Rs exert a neurotrophic action on neuronal development *in vivo*. Some signaling pathways have been identified, involving changes in calcium and cAMP levels, but much remained to be done. *In vitro* studies have shown that the stimulation of GABA~B~-Rs leads to a translocation of the transcriptor factor 4 (ATF4; [@B108]; [@B104]) and to the phosphorylation cAMP-response element binding (CREB). The interactions with ATF4 and/or CREB may be important to regulate gene expression and may underlie some of the neurotrophic actions of the GABA~B~-Rs. Accordingly, the direct activation of GABA~B~-Rs, in the presence of TTX to block spontaneous synaptic activity, leads to an up-regulation of BDNF expression, a key modulator of neuronal network wiring ([@B40]).

A recent study has revealed that patients with autoimmune encephalitis associated with antibodies to GABA~B1~ subunits show seizures, confusion and memory deficit ([@B63]). Moreover, some GABA~B~-R polymorphisms confer a highly increased susceptibility to temporal-lobe epilepsy in human beings ([@B35]; [@B107]). Thus, defective GABA~B~-Rs functions in the brain could underlie neurological and psychiatric diseases. It is therefore tempting to speculate that children exposed to drugs that affect GABA levels or act on GABA~B~-Rs during their fetal or postnatal life may develop GABA~B~-R related developmental disorders. In future studies, it will be essential to consider the emerging role of GABA~B~-Rs in network formation to fully understand the neurotrophic role of GABA and pathological consequences of altered GABAergic signaling.
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